Physician

Leonard Mark Dzubow, MD

According to 2025 Medicare claims, Leonard Dzubow, MD (NPI: 1790778199) practices micrographic dermatologic surgery in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is DERMATOLOGY LTD (NPI: 1477508257; TIN: 231730904) and primary practice location at 19063-1761.

Dzubow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 665 traditional Medicare patients, billed 2,011 HCPCS/CPT codes, and received $757,975 in Medicare payments. The top billing code was 17313 (Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks). Part D data shows 1,029 prescription claims across 666 beneficiaries totaling $8,809 in drug costs, led by Mupirocin (Mupirocin). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$491K$981K2015 Medicare payment: $974,560 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $981,326 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $957,718 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $824,644 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $760,812 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $707,607 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $770,888 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $744,675 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $833,794 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $757,975 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157952,942$974,560
20167762,829$981,326
20178042,757$957,718
20187692,109$824,644
20196581,910$760,812
20206011,770$707,607
20216351,899$770,888
20226441,853$744,675
20236952,105$833,794
20246652,011$757,975

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.7K$11K2015 Drug cost: $11,305 (USD; Tot_Drug_Cst)2016 Drug cost: $11,304 (USD; Tot_Drug_Cst)2017 Drug cost: $9,927 (USD; Tot_Drug_Cst)2018 Drug cost: $10,143 (USD; Tot_Drug_Cst)2019 Drug cost: $8,492 (USD; Tot_Drug_Cst)2020 Drug cost: $10,657 (USD; Tot_Drug_Cst)2021 Drug cost: $11,059 (USD; Tot_Drug_Cst)2022 Drug cost: $8,905 (USD; Tot_Drug_Cst)2023 Drug cost: $9,544 (USD; Tot_Drug_Cst)2024 Drug cost: $8,809 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015554831$11,305
2016585895$11,304
2017618872$9,927
2018586841$10,143
2019531779$8,492
2020547952$10,657
2021575983$11,059
2022619920$8,905
20236671,025$9,544
20246661,029$8,809

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17313Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks7280$507
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks583750$482
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks326521$340
13132Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm155170$195
88342Special stained specimen slides to examine tissue, initial procedure79134$87

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MupirocinMupirocin76910,645$4,910
Gentamicin SulfateGentamicin Sulfate1201,621$2,336
CephalexinCephalexin65455$293
Doxycycline HyclateDoxycycline Hyclate31223$208
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1334$26

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Leonard Mark Dzubow, MD?

Tedicare shows public-source Medicare data for Leonard Mark Dzubow, MD (NPI 1790778199), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Leonard Mark Dzubow, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Leonard Mark Dzubow, MD?

Leonard Mark Dzubow, MD is linked to DERMATOLOGY LTD (billing NPI 1477508257) in the available physician profile data.

Does Leonard Mark Dzubow, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.